Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christophe Dooms

Showing results (81-90 of 138) with videos related to

Pageof 14
Sort By:
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 8, 2016
Detection of Lung Cancer through Metabolic Changes Measured in Blood PlasmaEvelyne Louis, Peter Adriaensens, Wanda Guedens, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|March 1, 2014
Revised ESTS guidelines for preoperative mediastinal lymph node staging for non-small-cell lung cancerPaul De Leyn, Christophe Dooms, Jaroslaw Kuzdzal, et al.
Translational Lung Cancer Research|March 26, 2015
Preoperative mediastinal lymph node staging for non-small cell lung cancer: 2014 update of the 2007 ESTS guidelinesPaul De Leyn, Christophe Dooms, Jaroslaw Kuzdzal, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 5, 2016
Patterns of Locoregional Relapses in Patients with Contemporarily Staged Stage III-N2 NSCLC Treated with Induction Chemotherapy and Resection: Implications for Postoperative Radiotherapy Target VolumesCharlotte Billiet, Dirk De Ruysscher, Stéphanie Peeters, et al.
Radiation Oncology (London, England)|July 19, 2018
RNA-sequencing in non-small cell lung cancer shows gene downregulation of therapeutic targets in tumor tissue compared to non-malignant lung tissueKobe Reynders, Els Wauters, Matthieu Moisse, et al.
Clinical Lung Cancer|November 20, 2003
Additional value of whole-body fluorodeoxyglucose positron emission tomography in the detection of distant metastases of non-small-cell lung cancerSigrid G Stroobants, Isabelle D'Hoore, Christophe Dooms, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 10, 2016
Outcome after PORT in ypN2 or R1/R2 versus no PORT in ypN0 Stage III-N2 NSCLC after Induction Chemotherapy and ResectionCharlotte Billiet, Stéphanie Peeters, Herbert Decaluwé, et al.
Lung Cancer (Amsterdam, Netherlands)|February 9, 2010
Meeting report: 2nd meeting of the European Thoracic Oncology Platform (ETOP)Rolf Stahel, Paul Baas, Corinne Faivre-Finn, et al.
Radiology|April 27, 2012
Malignant pleural disease: diagnosis by using diffusion-weighted and dynamic contrast-enhanced MR imaging--initial experienceJohan Coolen, Frederik De Keyzer, Philippe Nafteux, et al.
European Journal of Cancer (Oxford, England : 1990)|October 27, 2019
Defining oligometastatic non-small cell lung cancer: A simulated multidisciplinary expert opinionLizza E L Hendriks, Christophe Dooms, Thierry Berghmans, et al.
Pageof 14

Showing results (81-90 of 138) with videos related to

Sort By:
Pageof 14
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 8, 2016
Detection of Lung Cancer through Metabolic Changes Measured in Blood PlasmaEvelyne Louis, Peter Adriaensens, Wanda Guedens, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|March 1, 2014
Revised ESTS guidelines for preoperative mediastinal lymph node staging for non-small-cell lung cancerPaul De Leyn, Christophe Dooms, Jaroslaw Kuzdzal, et al.
Translational Lung Cancer Research|March 26, 2015
Preoperative mediastinal lymph node staging for non-small cell lung cancer: 2014 update of the 2007 ESTS guidelinesPaul De Leyn, Christophe Dooms, Jaroslaw Kuzdzal, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 5, 2016
Patterns of Locoregional Relapses in Patients with Contemporarily Staged Stage III-N2 NSCLC Treated with Induction Chemotherapy and Resection: Implications for Postoperative Radiotherapy Target VolumesCharlotte Billiet, Dirk De Ruysscher, Stéphanie Peeters, et al.
Radiation Oncology (London, England)|July 19, 2018
RNA-sequencing in non-small cell lung cancer shows gene downregulation of therapeutic targets in tumor tissue compared to non-malignant lung tissueKobe Reynders, Els Wauters, Matthieu Moisse, et al.
Clinical Lung Cancer|November 20, 2003
Additional value of whole-body fluorodeoxyglucose positron emission tomography in the detection of distant metastases of non-small-cell lung cancerSigrid G Stroobants, Isabelle D'Hoore, Christophe Dooms, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 10, 2016
Outcome after PORT in ypN2 or R1/R2 versus no PORT in ypN0 Stage III-N2 NSCLC after Induction Chemotherapy and ResectionCharlotte Billiet, Stéphanie Peeters, Herbert Decaluwé, et al.
Lung Cancer (Amsterdam, Netherlands)|February 9, 2010
Meeting report: 2nd meeting of the European Thoracic Oncology Platform (ETOP)Rolf Stahel, Paul Baas, Corinne Faivre-Finn, et al.
Radiology|April 27, 2012
Malignant pleural disease: diagnosis by using diffusion-weighted and dynamic contrast-enhanced MR imaging--initial experienceJohan Coolen, Frederik De Keyzer, Philippe Nafteux, et al.
European Journal of Cancer (Oxford, England : 1990)|October 27, 2019
Defining oligometastatic non-small cell lung cancer: A simulated multidisciplinary expert opinionLizza E L Hendriks, Christophe Dooms, Thierry Berghmans, et al.
Pageof 14